Michael Wacker ^Investor

Michael Wacker is a seasoned entrepreneur with 20 years of experience in the life science industry. As a General Partner at a Venture Capital Fund, he leverages his expertise to drive success for biotech companies. With a PhD in microbiology from ETH Zurich, he founded GlycoVaxyn, leading it to significant growth and securing over 40m USD in funding. Michael is a prolific author and inventor, with publications in prestigious journals like Science and PNAS. His passion lies in developing innovative vaccines to combat bacterial infections, showcasing his commitment to advancing healthcare.